10 Affordable Biotech Stocks to Buy Right Now
In this article, we will take a look at some of the most affordable biotech stocks that are currently offering attractive upside potential.
Dyne Therapeutics Inc. (DYN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Orbis Investment Management William B. Gray | 7,006,542 | $155,615,298 | +4% | 0.53% |
| 2. | Vestal Point Capital Ryan Wilder | 3,375,000 | $74,958,750 | -16% | 1.75% |
| 3. | OrbiMed Advisors Samuel Isaly | 3,235,684 | $71,864,542 | +11% | 1.33% |
| 4. | Armistice Capital Steven Boyd | 3,087,226 | $68,567,289 | -3% | 0.84% |
| 5. | Perceptive Advisors Joseph Edelman | 2,689,235 | $59,727,909 | -43% | 0.9% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.94 | 2,000 | $33,880.00 | 24,500 | 2026-06-08 | Filing | |
| $17.48 | 2,500 | $43,700.00 | 22,500 | 2026-06-03 | Filing | |
| $18.21 | 2,000 | $36,420.00 | 20,000 | 2026-05-26 | Filing | |
| $17.12 | 2,500 | $42,800.00 | 18,000 | 2026-05-20 | Filing | |
| $17.08 | 2,000 | $34,160.00 | 15,500 | 2026-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.88 | 185 | $3,492.80 | 152,897 | 2026-09-08 | Filing | |
| $24.35 | 900 | $21,915.00 | 153,082 | 2026-09-04 | Filing | |
| $18.88 | 1,290 | $24,355.20 | 162,564 | 2026-09-08 | Filing | |
| $24.35 | 3,745 | $91,190.75 | 163,854 | 2026-09-04 | Filing | |
| $18.88 | 5,658 | $106,823.04 | 357,507 | 2026-09-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,404,330 | $275,500,169 | 0% | |
| 2. | 11,997,738 | $266,634,150 | 0.11% | |
| 3. | 11,207,000 | $248,907,468 | 0.01% | |
| 4. | 7,458,263 | $165,648,021 | 0% | |
| 5. | 6,800,099 | $151,030,199 | 17.14% |
News See All
10 Best Upside Stocks to Buy According to Hedge Funds
In this article, we will discuss the 10 Best Upside Stocks to Buy According to Hedge Funds.
10 Best AI Driven Biotech Stocks to Invest In
In this article, we will take a look at some of the best AI driven biotech stocks that are currently offering attractive upside potential.
Clearbridge Small Cap Growth Strategy Added Dyne Therapeutics (DYN) in Q4
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” Q4 2025 investor letter. A copy of the letter can be downloaded here.
Dyne Therapeutics (DYN) Shares Key Details For Pivotal. Drugs
Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 11 Best Day Trading Stocks to Buy Now. Earlier this month, Dyne Therapeutics Inc.
Dyne Therapeutics (DYN) Climbs 11.8% on Triple-Digit Price Target Upgrade
Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 10 Stocks Investors Are Watching.
10 Stocks Investors Are Watching: WiPro, USAR, NIO, and More
Ten stocks soared higher on Tuesday, bucking a lackluster performance in the broader market, as investors took path from a flurry of positive developments including analyst ratings and earnings, among...
Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan
Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 13 hot stocks to buy with the highest upside potential.
13 Hot Stocks to Buy with the Highest Upside Potential
In this article, we talk about the 13 hot stocks to buy with the highest upside potential.
Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry
Dyne Therapeutics (NASDAQ:DYN) is one of the 17 biotechnology stocks with more than 50% upside. As of the February 12 closing, Dyne Therapeutics (NASDAQ:DYN) held a strongly bullish consensus view.
Hedge Fund Resource Center